SLC2A4 and Insulin resistance: Mattei L. et al. reported that the treatment with γ-oryzanol improved insulin resistance, reduced inflammation, increased antioxidant response and glucose transporter-4 (GLUT-4) expression in skeletal muscles of obese animals [49].